Literature DB >> 3311885

Expression, purification and characterization of recombinant murine granulocyte-macrophage colony-stimulating factor and bovine interleukin-2 from yeast.

V Price1, D Mochizuki, C J March, D Cosman, M C Deeley, R Klinke, W Clevenger, S Gillis, P Baker, D Urdal.   

Abstract

Expression and secretion of two lymphokines, murine granulocyte-macrophage colony-stimulating factor (MuGM-CSF) and bovine interleukin-2 (BoIL-2), to levels of 50-60 mg per liter were achieved by placing these cDNAs in a Saccharomyces cerevisiae expression vector that utilized the yeast alcohol dehydrogenase-2 promoter and alpha-factor leader peptide. These lymphokines were purified to homogeneity by direct application of the crude yeast medium to reversed-phase high-performance liquid chromatography. Despite the fact that both lymphokines contain at least one N-glycosylation site and have identical N-terminal residues (Ala-Pro-Thr), recombinant (R) GM-CSF was found to be heterogeneously glycosylated by yeast while RBoIL-2 was secreted without glycosylation. Additionally, approximately 40% of the RGM-CSF was found to be proteolytically cleaved after the second amino acid residue, while RBoIL-2 was found to be intact.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311885     DOI: 10.1016/0378-1119(87)90288-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  An approach to computer-aided inhibitor design: application to cathepsin L.

Authors:  S Sudarsanam; G D Virca; C J March; S Srinivasan
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

2.  Purified murine granulocyte/macrophage progenitor cells express a high-affinity receptor for recombinant murine granulocyte/macrophage colony-stimulating factor.

Authors:  D E Williams; D C Bicknell; L S Park; J E Straneva; S Cooper; H E Broxmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein.

Authors:  B M Curtis; D E Williams; H E Broxmeyer; J Dunn; T Farrah; E Jeffery; W Clevenger; P deRoos; U Martin; D Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

4.  A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines.

Authors:  P E Duffy; D C Kaslow
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.

Authors:  D K Pettit; J R Lawter; W J Huang; S C Pankey; N S Nightlinger; D H Lynch; J A Schuh; P J Morrissey; W R Gombotz
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

6.  Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.

Authors:  S Kumar; W Collins; A Egan; A Yadava; O Garraud; M J Blackman; J A Guevara Patino; C Diggs; D C Kaslow
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Purification and characterization of recombinant human interleukin 4. Biological activities, receptor binding and the generation of monoclonal antibodies.

Authors:  R Solari; D Quint; H Obray; A McNamee; E Bolton; P Hissey; B Champion; E Zanders; A Chaplin; B Coomber
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

8.  Interleukin-1 administration to C3H/HeJ mice after but not prior to infection increases resistance to Salmonella typhimurium.

Authors:  P J Morrissey; K Charrier
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

Authors:  S Kumar; A Yadava; D B Keister; J H Tian; M Ohl; K A Perdue-Greenfield; L H Miller; D C Kaslow
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

10.  Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells.

Authors:  R G Goodwin; S Lupton; A Schmierer; K J Hjerrild; R Jerzy; W Clevenger; S Gillis; D Cosman; A E Namen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.